A terapia antiagregante é comumente indicada na prevenção e tratamento de doenças cardiovasculares. A dupla antiagregação com clopidrogrel e ácido acetilsalicílico (AAS) tem sido frequentemente adotada em pacientes com Doença Arterial Coronariana (DAC), mas apresenta ineficácia em uma parcela significativa da população com genótipo de respondedores. Essa falha terapêutica nos leva a questionar se outros mecanismos moleculares podem estar influenciando na resposta a esses fármacos. Recentes estudos sugerem que pequenas sequências de RNA não codificantes denominadas microRNAs (miRNAs) podem estar fortemente relacionadas com resposta ao tratamento fármaco-terapêutico, controlando as proteínas envolvidas na farmacocinética e farmacodinâmica. Entretanto, os principais miRNAs que atuam na dinâmica da resposta medicamentosa ainda não foram bem definidos. O objetivo deste estudo foi avaliar o perfil de miRNAs no sangue total periférico, procurando melhor esclarecer os mecanismos envolvidos na resposta aos antiagregantes plaquetários AAS e clopidogrel. Para isso, selecionou-se pacientes com DAC, os quais apresentavam diferentes respostas à dupla terapia de antiagregação determinadas pelo teste de agregação plaquetária. Baseados nos fenótipos, os perfis de expressão de miRNAs foram comparados entre os valores da taxa de agregação categorizados em tercis (T) de resposta. O grupo T1 foi constituído de pacientes respondedores, o T2 de respondedores intermediários e o T3 de não respondedores. Os perfis de miRNAs foram obtidos após sequenciamento de última geração e os dados obtidos foram analisados pelo pacote Deseq2. Os resultados mostraram 18 miRNAs diferentemente expressos entre os dois tercis extremos. Dentre esses miRNAs, 10 deles apresentaram importantes alvos relacionados com vias de ativação e agregação plaquetária quando analisados pelo software Ingenuity®. Dos 10 miRNAs, 4 deles, os quais apresentaram-se menos expressos no sequenciamento, demonstraram os mesmos perfis de expressão quando analisados pela reação em cadeia pela polimerase quantitativa (qPCR): hsa-miR-423-3p, hsa-miR-744-5p, hsa-miR- 30a-5p e hsa-let-7g-5p. A partir das análises de predição de alvos, pôde-se observar que os quatro miRNAs, quando menos expressos simultaneamente, predizem ativação da agregação plaquetária. Além disso, os miRNAs hsa-miR- 423-5p, hsa-miR-744-5p e hsa-let-7g-5p mostraram correlação com o perfil lipídico dos pacientes que, por sua vez, apresentou influência nos valores de agregação compreendidos no T3 de resposta a ambos os medicamentos. Sendo assim, conclui-se que maiores taxas de agregação plaquetária podem estar indiretamente relacionadas com os padrões de expressão de hsa-miR- 423-3p, hsa-miR-744-5p e hsa-let-7g-5p. Sugere-se que a avaliação do perfil de expressão destes 3 miRNAs no sangue periférico de pacientes com DAC possa predizer resposta terapêutica inadequada ao AAS e ao clopidogrel / The antiplatelet therapy is often indicated for the prevention and treatment of cardiovascular diseases. Dual antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA) has often been adopted in patients with coronary artery disease (CAD), but it has been ineffective in a significant portion of the population with genotype of responders. This fact leads us to question whether other molecular mechanisms may be influencing the response to these drugs. Recent studies suggest that small non-coding RNA sequences known as microRNAs (miRNAs) may be closely related to response to drug-therapeutic treatment, controlling proteins involved in pharmacokinetics and pharmacodynamics. The aim of this study was to evaluate the profile of miRNAs in whole blood, looking to better clarify mechanisms involved in ASA and clopidogrel response. For this purpose, we selected CAD patients who showed different responses to dual antiplatelet therapy determined by aggregation test. Based on the phenotypes, the miRNA expression profiles were compared between the platelet aggregation values categorized into tertiles (T) of response. The T1 group consisted of responding patients, the T2 consisted of intermediate responders and the T3 consisted of non-responders. The miRNA profiles were obtained after next-generation sequencing and data were analyzed by Deseq2 package. Results showed that 18 miRNAs were differentially expressed between the two extreme tertiles. By Ingenuity® software prediction analysis, 10 miRNAs showed important targets related with activation and aggregation of blood platelets. Of the 10 miRNAs, 4 of them, which were down-expressed on sequencing, showed the same fold-regulation when expression profiles were analyzed by quantitative polymerase chain reaction (qPCR): hsa-miR-423-3p, hsa-miR-744-5p, hsa-miR-30a-5p and has-hsa- let-7g-5p. By target prediction analysis, it was observed that, when the four miRNAs are simultaneously down-expressed, they predict activation of platelet aggregation. Furthermore, hsa-miR-423-5p, hsa-miR-744-5p, and hsa-let-7g-5p showed correlation with the lipid profile of patients which, in turn, demonstrated influence in aggregation values reaching T3 of response to both drugs. Therefore, we concluded that increased platelet aggregation rates may be indirectly related to the expression profiles of hsa-miR-423-3p, hsa-miR-744-5p and hsa-let-7g-5p. It is suggested that the evaluation of the expression profile of these three miRNAs in the peripheral blood of patients with CAD may predict inadequate therapeutic response to aspirin and clopidogrel.

Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico / As redes locais sem fio (Wireless Local Area Networks - WLANs) IEEE 802.11 atingem taxas de transmissÃo de dados relativamente altas quando comparadas `a outras redes sem fio, por exemplo, Bluetooth. Essas altas taxas de transmissÃao tÃm interessado as operadoras de redes celulares, as quais comeÃam a ver as redes IEEE 802.11 como um complemento as suas redes de acesso. Esta interoperabilidade entre sistemas celulares e WLANs tem sido um tema bastante discutido na literatura. Por exemplo, o 3GPP (Third Generation Partnership Project) define seis nÂıveis para a total integraÃÃo das redes celulares de terceira geraÃÃo com as redes locais sem fio. No entanto, a integraÃÃo com suporte a mobilidade ainda nÃo foi especificada, o que à necessÃrio para viabilizar a transparÃncia de transmissÃo de voz e dados para os usuÃrios finais. Esta dissertaÃÃo apresenta entÃo duas abordagens para o gerenciamento de mobilidade na integraÃÃo do sistema 3G UMTS com as redes IEEE 802.11: uma baseada no SIP (Session Initiation Protocol ) e a outra no MIP versÃo 6 (Mobile IP version 6 - MIPv6). A proposta estende a arquitetura Loose Interworking e utiliza os requisitos do nÃvel 4 do 3GPP. Para especificar a proposta, as abordagens de integraÃÃo das redes UMTS e IEEE 802.11 foram modeladas em diagramas de seqÃÃncia e, em seguida, mapeadas para a tÃcnica de descriÃÃo formal SDL (Specification and Description Language). SDL, que à bastante utilizada para especificar formalmente sistemas de telecomunicaÃÃes, apresenta procedimentos de simulaÃÃo e validaÃÃo que sÃo aplicados para avaliar a especificaÃÃo e, em conseqÃÃncia, as abordagens propostas. / Wireless Local Area Networks (WLANs) IEEE 802.11 reach relatively high data transmission rates when compared to other wireless networks, such as Bluetooth. These high data transmission rates have gained attention from the cellular networks operators, which have been considering IEEE 802.11 networks as a complement to their access networks. This interoperability between cellular systems and WLANs has been frequently discussed in the literature. For example, 3GPP (Third Generation Partnership Project) has defined six levels for the complete integration of the third generation cellular networks and WLANs. However, the mobility support has not been specified yet, which is necessary to make feasible voice and data transmission transparence for the final users. Thus, this work presents two approaches for the mobility management of the integration between UMTS and IEEE 802.11 networks: the first one is based on SIP (Session Initiation Protocol), and the other one is based on MIPv6 (Mobile IP version 6). This proposal extends the Loose Interworking architecture and uses the fourth level of the 3GPP specification. First, these approaches are modeled using sequence diagrams and, then, they are mapped to the SDL (Specification and Description Language) formal description technique. SDL, which is largely used to formally specify telecommunications systems, presents simulation and validation procedures that are applied to evaluate the specification and, consequently, the proposed approaches.

A cor da pele, olhos e cabelos são alguns dos traços fenotípicos mais aparentes quando nos referimos à identificação de características individuais. Essas características frequentemente são utilizadas na descrição de indivíduos em retratos falados usados em investigações policiais. Porém, em muitos casos as vítimas ou testemunhas não reconhecem o agressor, tornando inviável a produção desses retratos. Contudo, os vestígios biológicos deixados pelo criminoso poderiam ser utilizados na predição de suas características físicas, suprindo a falta ou complementando o retrato falado. Para que isso seja possível, é preciso conhecer as variáveis responsáveis pela formação desses fenótipos. No caso dos fenótipos de pigmentação há tanto um fator genético, quanto ambiental. Diversos genes participam da formação desses fenótipos, dentre eles está o gene MITF (Melanogenesis-associated transcription factor), um dos principais regulador da biossíntese de melanina nos melanócitos. Esse gene está fortemente associado às síndromes de Waadenburg e Tietz, as quais causam pigmentação anormal, principalmente na pele, e ao melanoma. No entanto, apesar do claro envolvimento do gene MITF na melanogênese, ainda não são conhecidas associações significativas de polimorfismos nesse gene com fenótipos de pigmentação. À vista disso, esse trabalho avaliou a relação da variabilidade do gene MITF com os fenótipos de pigmentação encontrados em uma amostra populacional do estado de São Paulo, por meio de sequenciamento de nova geração. Foram identificados 133 pontos de variação em toda a extensão do gene e sua região promotora, dos quais 21 estão associadas a pelo menos um fenótipo de pigmentação de pele, olhos ou cabelo. Adicionalmente foram encontradas associações com ao menos um fenótipo de pigmentação para 3 dos 17 haplótipos da região promotora, 7 dos 50 haplótipos da extensão que engloba a região 5UTR e codificante, e um dos 18 haplótipos encontrados na região 3UTR. Considerando os haplótipos encontrados para a extensão total do gene MITF e sua promotora, 20 dos 132 haplótipos encontrados estão associados a algum fenótipo de pigmentação. A maior parte das associações encontradas, tanto para alelos e genótipos quanto para haplótipos, são referentes a fenótipos mais escuros como cabelos castanhos escuros e pretos e pele escura. Associações com fenótipos mais claros, tais como olhos azuis e verdes e cabelos loiros e ruivos, também foram encontradas, porém envolvendo variantes e haplótipos de frequência baixa na população amostrada; tais associações, entretanto, representam achados falsos positivos. Os resultados confirmam a hipótese de que a variabilidade do gene MITF pode contribuir para a formação dos fenótipos de pigmentação de pele, olhos e cabelos dos indivíduos da população brasileira / Skin, eye and hair colors are some of the most noticeable phenotypes when referring to the identification of individual characteristics. These characteristics are often used to describe individuals in police sketches used in investigations. However, in many cases the victims or witnesses are unable to recognize the assaulter, making this sketches unfeasible. Nonetheless, biological traces left by the assaulter could be used to predict their physical characteristics, compensating or complementing these sketches. To make this possible, its necessary to know the variables responsible for the development of these traits. Pigmentation phenotype development relies on genetic and environmental aspects. A variety of genes contribute to the development of these phenotypes, among them MITF (Melanogenesis-associated transcription factor), one of the main regulators of melanin synthesis in melanocytes. This gene is strongly associated with Waardenburg and Tietz syndrome, which cause abnormal pigmentation, mostly in skin, and melanoma. Although MITFs clear involvement in melanogenesis, significant associations between this genes polymorphisms and pigmentation phenotypes are still unknown. Thus, this study evaluated the relation between MITF genetic variability and pigmentation phenotypes found in a population sample from the state of São Paulo, through next generation sequencing. There were identified 133 variation points through the whole gene and its promoter, from which 21 were associated with at least one skin, eye or hair pigmentation phenotype. Additionally, 3 of the 17 promoter haplotypes, 7 of the 50 haplotypes comprising the 5UTR and coding regions and one of the 18 3UTR haplotypes were associated with at least one pigmentation phenotype. Considering the haplotypes found for the whole gene and its promoter, 20 of the 132 haplotypes found were associated with at least one phenotype. The majority of the associations found for alleles, genotypes and haplotypes were related to darker phenotypes, like dark brown and black hair and dark skin. Associations with lighter phenotypes, like blue and green eyes and blonde and red hair, were also found, although involving variants and haplotypes with low frequencies in the studied population; these associations, however, represent false positives. The results corroborate the hypothesis that the MITF variability can contribute to the formation of pigmentation phenotypes in skin, eye and hair in the Brazilian population

Abstract: Recent advances in Next-Generation Sequencing protocols have opened a variety of ways to generate data. However, each newly developed methodology is most suited to represent a certain phenomenon or molecule. The object of this analysis is to identify the most appropriate way to generate and process data to study the snoRNAs, or small nucleolar RNA. Recently, snoRNAs have been revealed as taking part in a variety of unexpected alternative functions such as splicing, resistance to oxidative shock and chromatin unwinding. Finding a method to generate and treat a large quantity of data containing snoRNAs and their potential interactors could highlight some of their unexplored roles within the cell. To tackle the problem, a new protocol was put forward. This new pipeline relies on a reverse transcriptase isolated from a bacterial group II intron which boasts a better representation of structured small RNAs such as tRNAs and snoRNAs. Indeed, when compared to data created by using the standard small RNA preparation protocol, the sequencing data generated through the group II intron retrotranscriptase gives a much fairer representation. These improvements are also present in the bioinformatics pipeline. The workflow was changed to facilitate the detection of ncRNAs. These modifications rescue millions of reads, further increasing the power of the analysis. Ultimately, such corrections increase the predictive power of sequencing data. / Des avancées récentes dans le domaine du séquençage de prochaine génération ont ouvert une panoplie de façons de générer des données. Toutefois, chaque nouvelle méthode dévelopée est souvent appropriée à la caractérisation d’un seul type de phénomène ou de molécules. L’objectif de cette analyse est d’identifier la manière la plus appropriée de générer et traiter les données pour étudier les petits ARNs nucléolaires, snoRNAs. Récemment, ceux-ci ont été révélés comme des acteurs dans une variété de fonctions alternatives comme l’épissage alternatif, la résistance au choc oxidatif et l’état de la chromatine. Il est donc impératif de trouver une méthode qui puisse traiter une large quantité de données contenant les snoRNAs et leurs intéracteurs pour découvrir les rôles encore inexplorés des snoRNAs. Dans cette optique, un nouveau protocole a été élaboré. Cette nouvelle suite d’analyses s’appuie sur une reverse transcriptase isolée d’un intron de groupe II bactérien qui affiche une meilleure représentation des petits ARNs structurés comme les tRNAs et les snoRNAs. En effet, quand les données générées à travers la méthode de préparation des libraries pour petits ARNs standard est comparée à celle basée sur la reverse transcriptase bactérienne, cette dernière donne une meilleure représentation du compte des espèces. Ces avancées sont aussi présentes dans la méthode d’analyse informatique. La suite d’outils a été modifiée afin de permettre une meilleure détection des petits ARN non-codants. Ces modifications permettent de récupérer des millions de lectures par ensemble de données ce qui augmente le pouvoir prédictif de l’analyse.

Recent years have witnessed that standard telecommunication services evolved more and more to next generation value-added services. This fact is accompanied by a change of service characteristics as new services are designed to fulfil the customer’s demands instead of just focussing on technologies and protocols. These demands can be very specific and, therefore, diverse potential service functionalities have to be considered by the service providers. To make matters worse for service providers, a fast transition from concept to market product and low price of a new service is required due to the increasing competition in the telecommunication industry. Therefore, effective test solutions need to be developed that can be integrated in current value-added service development life-cycles. Besides, these solutions should support the involvement of all participating stakeholders such as the service provider, the test developers as well as the service developers, and, in order to consider an agile approach, also the service customer. This thesis proposes a novel framework for functional testing that is based on a new sort of description language for value-added services (Service Test Description). Based on instances of the Service Test Description, sets of reusable test components described by means of an applied Statecharts notation are automatically selected and composed to so-called behaviour models. From the behaviour models, abstract test cases can be automatically generated which are then transformed to TTCN-3 test cases and then assembled to an Executable Test Suite. Within a TTCN-3 test system, the Executable Test Suite can be executed against the corresponding value-added service referred to as System Under Test. One benefit of the proposed framework is its application within standard development life-cycles. Therefore, the thesis presents a methodology that considers both service development and test development as parallel tasks and foresees procedures to synchronise the tasks and to allow an agile approach with customer involvement. The novel framework is validated through a proof-of-concept working prototype. Example value-added services have been chosen to illustrate the whole process from compiling instances of the Service Test Description until the execution of automated tests. Overall, this thesis presents a novel solution for service providers to improve the quality of their provided value-added services through automated functional testing procedures. It enables the early involvement of the customers into the service development life-cycle and also helps test developers and service developers to collaborate.

Cancer related mortality is almost always due to metastatic dissemination of the primary disease. While research into the biological mechanisms that drive the metastatic cascade continues to unravel its molecular underpinnings, progress in our understanding of biological phenomena such as tumour heterogeneity and its relevance to the origins of distant recurrence or the emergence of resistance to therapy has been limited.In parallel to major breakthroughs in the development of high throughput molecular techniques, researchers have begun to utilise next generation sequencing to explore the relationship between primary and matched metastatic tumours in diverse types of neoplasia. Despite small cohort sizes and often, a limited number of matched metastases for each patient, pioneering studies have uncovered hitherto unknown biological processes such as the occurrence of organ specific metastatic lineages, polyclonal seeding and homing of metastatic cells to the primary tumour bed. While yet other studies continue to highlight the potential of genomic analyses, at the time this thesis was started, an in-depth knowledge of disease progression and metastatic dissemination was currently lacking in breast cancers.Herein, we employed phylogenetic inference methods to investigate intra-tumour heterogeneity and evolution of breast cancers. A combination of whole exome sequencing, custom ultra-deep resequencing and copy number profiling were applied to primary tumours and their associated metastases from ten autopsied breast cancer patients. Two modes of metastatic progression were observed. In the majority of cases, all distant metastases clustered on a branch separate from their primary lesion. Clonal frequency analysis of somatic mutations showed that the metastases had a monoclonal origin and descended from a common metastatic precursor. Alternatively, the primary tumour was clustered alongside metastases with early branches leading to distant organs. This dichotomy coincided with the clinical history of the patients whereby multiple seeding events from the primary tumour alongside cascading metastasis-to-metastasis disseminations occurred in treatment naïve de novo metastatic patients, whereas descent from a common metastatic precursor was observed in patients who underwent primary surgery followed by systemic treatment. The data also showed that a distant metastasis can be horizontally cross-seeded and finally revealed a correlation between the extent of somatic point mutations private to the distant lesions and patient overall survival. In an unrelated dataset of relapsed breast cancer patients with matched primary and distant lesions profiled using whole genome sequencing, the landscape of somatic alterations confirmed the time dependency of copy number aberrations implying that cancer phylogenies can be dated using a molecular clock.The work presented here harnesses the strength of high throughput genomic techniques and state of the art phylogenetic tools to tell the evolutionary history of breast cancers. Our results show that the linear and parallel models of metastatic dissemination which have been held as near doctrines for many years are overstated point of views of cancer progression. Beyond the biological insights, these results suggest that surgical excision of the primary tumour in de novo metastatic breast cancers might reduce dissemination in selected cases hence providing a potential biological rationale for this practice. Similarly, there is no strong evidence of benefit in overall survival from surgical resection of oligo-metastases in breast cancer. From our analyses, metastatic lesions constitute an additional source of seeding and heterogeneity in advanced breast cancer. The data presented here is too small to derive practice-changing evidence, but supports the concept that resecting isolated metastases may be of clinical benefit in oligo-metastatic breast cancer patients. In both cases, results from larger prospective studies are warranted. / Doctorat en Sciences biomédicales et pharmaceutiques (Médecine) / info:eu-repo/semantics/nonPublished

Ce travail de thèse illustre l’intérêt d’utiliser le séquençage de nouvelle génération (Next- Generation Sequencing ou NGS) pour améliorer le diagnostic moléculaire des formes de prédispositions aux cancers. Nous avons appliqué deux stratégies différentes, l’une basée sur l’analyse simultanée d’un panel de gènes impliqués dans une pathologie, l’autre sur l’analyse de toutes les parties codante du génome ou exome.Nous avons montré que le développement d’un panel de 10 gènes impliqués dans la carcinogenèse des cancers coliques a permis d’améliorer le diagnostic moléculaire de ces formes de cancers. Cette technologie a diminué le délai de rendu des résultats et est plus sensible que le séquençage Sanger et la QMPSF (Quantitative Multiplex PCR of Short Fragment).L’application d’une stratégie d’analyse d’exomes de trio par NGS, à l’analyse de deux formes de cancers sporadiques de phénotype extrême, cancers du sein et de l’ovaire, a permis la détection de mutations de novo portant sur des gènes impliqués dans l’oncogenèse. Pour mettre en cause ces mutations dans le phénotype, nous avons réalisé des tests fonctionnels et des études de récurrence. / The working thesis Illustre interest of the USE next generation sequencing (NGS Next- Generation Sequencing e) pay Improve Molecular diagnosis of predisposition to cancer forms. Have we applied two different strategies you in June based on the simultaneous analysis of genes not involved in panel A pathology, the Other on the analysis of all the parties of the coding genome e exome.Nous Have Shown que le development of a panel of 10 genes involved in carcinogenesis of colon cancer a Permit to improve the molecular diagnosis of forms of CES dE cancers. This technology has reduced the Delai rendering results and is more reasonable That Sanger sequencing and QMPSF (Quantitative Multiplex PCR of Short Fragment) .The application OF exomes an analysis by NGS trio Strategy at analysis of two forms of sporadic cancer phenotype extreme, breast cancer and ovarian cancer, permit the detection of de novo mutations on genes involved in oncogenesis. For Questioning mutations IN THESE phenotype, We Have made Functional testing and induction studies.

Observations of floral development indicate that floral organ initiation in pentapetalous flowers more commonly results in a medially positioned abaxial petal (MAB) than in a medially positioned adaxial petal (MAD), where the medial plane is defined by the stem and the bract during early floral development. It was proposed that the dominant MAB petal initiation might impose a developmental constraint that leads to the evolution of limited patterns of floral zygomorphy in Asteridae, a family in which the floral zygomorphy develops along the medial plane and results in a central ventral (CV) petal in mature flowers. Here, I investigate whether the pattern of floral organ initiation may limit patterns of floral zygomorphy to evolve in pentapetalous angiosperms. I analyzed floral diagrams representing 405 species in 330 genera of pentapetalous angiosperms to reconstruct the evolution of floral organ initiation and the evolution of developmental processes that give rise to floral zygomorphy on a phylogenetic framework. Results indicate that MAB petal initiation is the most common; it occupies 86.2% of diversity and represents the ancestral state of floral organ initiation in pentapetalous angiosperms. The MAD petal initiation evolved 28 times independently from the ancestral MAB petal initiation. Among the 34 independent originations of floral zygomorphy, 76.5% of these clades represent MAB petal initiation, among which only 47% of the clades result a CV petal in mature flowers. The discrepancy is explained by the existence of developmental processes that result in floral zygomorphy along oblique planes of floral symmetry in addition to along the medial plane. Findings suggest that although the early floral organ initiation plays a constraining role to the evolution of patterns of floral zygomorphy, the constraint diverges along phylogenetically distantly related groups that allow the independent originations of floral zygomorphy through distinct development processes in pentapetalous angiosperms. In additional study, the butterfly-like flowers of Schizanthus are adapted to pollination by bees, hummingbirds, and moths. I investigated the genetic basis of the zygomorphic corolla, for which development is key to the explosive pollen release mechanism found in the species of Schizanthus adapted to bee pollinators. I examined differential gene expression profiles across the zygomorphic corolla of Schizanthus pinnatus, a bee-pollinated species, by analyzing RNA transcriptome sequencing (RNA- seq). Data indicated that CYC2 is not expressed in the zygomorphic corolla of Sc. pinnatus, suggesting CYC2 is not involved in the development of floral zygomorphy in Schizanthus (Solanaceae). The data also indicated that a number of genes are differentially expressed across the corolla.

Brain disorders present a significant burden on affected individuals, their families and society at large. Existing diagnostic tests suffer from a lack of genetic biomarkers, particularly for substance use disorders, such as alcohol dependence (AD). Numerous studies have demonstrated that AD has a genetic heritability of 40-60%. The existing genetics literature of AD has primarily focused on linkage analyses in small family cohorts and more recently on genome-wide association analyses (GWAS) in large case-control cohorts, fueled by rapid advances in next generation sequencing (NGS). Numerous AD-associated genomic variations are present at a common frequency in the general population, making these variants of public health significance. However, known AD-associated variants explain only a fraction of the expected heritability. In this dissertation, we demonstrate that systems biology applications that integrate evolutionary genomics, rare variants and structural variation can dissect the genetic architecture of AD and elucidate its heritability. We identified several complex human diseases, including AD and other brain disorders, as potential targets of natural selection forces in diverse world populations. Further evidence of natural selection forces affecting AD was revealed when we identified an association between eye color, a trait under strong selection, and AD. These findings provide strong support for conducting GWAS on brain disorder phenotypes. However, with the ever-increasing abundance of rare genomic variants and large cohorts of multi-ethnic samples, population stratification becomes a serious confounding factor for GWAS. To address this problem, we designed a novel approach to identify ancestry informative single nucleotide polymorphisms (SNPs) for population stratification adjustment in association analyses. Furthermore, to leverage untyped variants from genotyping arrays – particularly rare variants – for GWAS and meta-analysis through rapid imputation, we designed a tool that converts genotype definitions across various array platforms. To further elucidate the genetic heritability of brain disorders, we designed approaches aimed at identifying Copy Number Variations (CNVs) and viral insertions into the human genome. We conducted the first CNV-based whole genome meta-analysis for AD. We also designed an integrated approach to estimate the sensitivity of NGS-based methods of viral insertion detection. For the first time in the literature, we identified herpesvirus in NGS data from an Alzheimer’s disease brain sample. The work in this dissertation represents a three-faceted advance in our understanding of brain disease etiology: 1) evolutionary genomic insights, 2) novel resources and tools to leverage rare variants, and 3) the discovery of disease-associated structural genomic aberrations. Our findings have broad implications on the genetics of complex human disease and hold promise for delivering clinically useful knowledge and resources.

La diffusion du séquençage haut débit (ou NGS pour Next Generation Sequencing) représente un tel changement d’échelle par rapport aux méthodes classiques de séquençage que les indications et l’organisation du diagnostic moléculaire s’en trouvent profondément modifiées. Le NGS permet à la fois de raccourcir le temps d’analyse et de rendu de résultat et d'élargir considérablement le nombre de gènes testés. Il promet donc d’augmenter la proportion de diagnostics posés et de faciliter l'identification de nouveaux variants et de nouveaux gènes impliqués en pathologie. Cependant dans tous les cas, il génère une quantité de données importante, données qui doivent être analysées et interprétées à l’aide d’outils bioinformatiques spécifiques.Dans la première partie de ce travail, les stratégies existantes ainsi que les difficultés et les enjeux du séquençage haut débit pour le diagnostic moléculaire des maladies génétiques sont discutés. Dans la deuxième partie, la mise en place et la validation technique de cette approche diagnostique sont décrites au sein du laboratoire de Génétique Moléculaire de la Timone à Marseille et illustrées par trois exemples concrets de diagnostics moléculaires posés grâce à la technique de séquençage à haut débit. Dans le domaine spécifique des maladies rares, ces nouvelles technologies sont porteuses d’un réel espoir pour les patients atteints de maladie génétique, permettant d'améliorer globalement leur prise en charge et d'accélérer les progrès dans le domaine de la recherche. / The diffusion of Next Generation Sequencing (NGS) technologies induces an important change that modifies molecular diagnostics indications and prompts laboratories to re-think their diagnostic strategies, up-to-now based on Sanger sequencing routine. Several high throughput approaches are available from the sequencing of a gene panel, to a whole exome, or even a whole genome. In all cases, a tremendous amount of data are generated, that have to be filtered, interpreted and analyzed by the use of powerful bioinformatics tools.In part 1, existing strategies and the difficulties and challenges of high-throughput sequencing for molecular diagnosis in genetic diseases are discussed. In part 2, the set up and the technical validation of this diagnostic approach in the Molecular Genetics’ Laboratory of the Timone Hospital in Marseille is presented and illustrated by 3 examples of complex diagnostics solved thanks to NGS. NGS promises to shorten significantly the time of analysis and results reporting, and to expand the number of tested genes. It also promises to increase the proportion of positive diagnoses. Finally, the NGS can identify new variants and new genes involved in human pathology, thus will globally improve patient clinical care.